Free ISG15 as a dimer generates IL-1β-producing CD8α+ dendritic cells at the site of infection release_gtajuzijmzbmfm7rrt4mocst5y

by Anna Napolitano, Annemarthe G van der Veen, Monique Bunyan, Annabel Borg, Svend Kjaer, Antje Beling, Klaus-Peter Knobeloch, Eva Frickel

Released as a post by Cold Spring Harbor Laboratory.

2017  

Abstract

ISG15 is strongly induced after type I IFN stimulation producing a protein comprised of two ubiquitin-like domains. Intracellularly, ISG15 can be covalently linked and modify the function of target proteins (ISGylation). In addition, free unconjugated ISG15 can be released from cells. We found that ISG15 is released in the serum of Toxoplasma gondii infected mice early after infection in a type-I IFN independent manner. Once in the extracellular space, free ISG15 forms dimers and enhances the release of key cytokines involved in the immune response to the parasite: IL-12, IFN-γ, and IL-1β. Its action is dependent on an actively invading and replicating live parasite. ISG15 induces an increase of IL-1β later during infection by leading to increased IL-1β producing CD8α+ dendritic cells at the site of infection. Here, we define for the first time the molecular determinants of active free ISG15 and link ISG15 to IL-1β production by CD8α+ dendritic cells. Thus we define ISG15 as a novel secreted modulator of the cytokine response during Toxoplasma infection.
In application/xml+jats format

Archived Files and Locations

application/pdf   10.0 MB
file_zsxg2yn4ebhdfnzmejcmyewcvi
web.archive.org (webarchive)
www.biorxiv.org (web)
application/pdf   10.0 MB
file_rtfpe4rsrjaqhmoldaxnaxrjzm
web.archive.org (webarchive)
www.biorxiv.org (web)
Read Archived PDF
Preserved and Accessible
Type  post
Stage   unknown
Date   2017-02-27
Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)
Catalog Record
Revision: 9bf30592-d67e-403a-9511-ea58bcebedd6
API URL: JSON